Trial · NCT02414399
Adverse events26
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 26
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Grade 3 (not reported by system) | General disorders | Azithromycin (n=702) | 0 | 702 | |
| other | Grade 3 (not reported by system) | General disorders | Placebo (n=696) | 0 | 696 | |
| other | Grade 2 (not reported by system) | General disorders | Azithromycin (n=702) | 193 | 702 | |
| other | Grade 2 (not reported by system) | General disorders | Placebo (n=696) | 195 | 696 | |
| other | Grade 1 (not reported by system) | General disorders | Azithromycin (n=702) | 81 | 702 | |
| other | Grade 1 (not reported by system) | General disorders | Placebo (n=696) | 81 | 696 | |
| serious | Grade 4 or 5 (cardiac disorders) | Cardiac disorders | Azithromycin (n=702) | 1 | 702 | |
| serious | Grade 4 or 5 (cardiac disorders) | Cardiac disorders | Placebo (n=696) | 1 | 696 | |
| serious | Grade 4 or 5 congenital disorders | Congenital, familial and genetic disorders | Azithromycin (n=702) | 0 | 702 | |
| serious | Grade 4 or 5 congenital disorders | Congenital, familial and genetic disorders | Placebo (n=696) | 1 | 696 | |
| serious | Grade 4 or 5 (gastrointestinal disorders) | Gastrointestinal disorders | Azithromycin (n=702) | 2 | 702 | |
| serious | Grade 4 or 5 (gastrointestinal disorders) | Gastrointestinal disorders | Placebo (n=696) | 0 | 696 | |
| serious | Grade 4 or 5 (general disorder) | General disorders | Azithromycin (n=702) | 1 | 702 | |
| serious | Grade 4 or 5 (general disorder) | General disorders | Placebo (n=696) | 2 | 696 | |
| serious | Grade 4 or 5 (infections) | Infections and infestations | Azithromycin (n=702) | 43 | 702 | |
| serious | Grade 4 or 5 (infections) | Infections and infestations | Placebo (n=696) | 43 | 696 | |
| serious | Grade 4 or 5 (injury or poisoning) | Injury, poisoning and procedural complications | Azithromycin (n=702) | 1 | 702 | |
| serious | Grade 4 or 5 (injury or poisoning) | Injury, poisoning and procedural complications | Placebo (n=696) | 1 | 696 | |
| serious | Grade 4 or 5 (renal & urinary disorder) | Renal and urinary disorders | Azithromycin (n=702) | 2 | 702 | |
| serious | Grade 4 or 5 (renal & urinary disorder) | Renal and urinary disorders | Placebo (n=696) | 1 | 696 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02414399/events